Abstract
Cardiovascular magnetic resonance imaging (CMR) plays an increasing role in the assessment of patients with various cardiovascular disorders. Given its enhanced spatial resolution, improved tissue characterization, and lack of ionizing radiation, it has become the test of choice in the evaluation of patients with new-onset cardiomyopathy of unknown etiology. In this paper, we will review the role of CMR in the evaluation of patients with various types of non-ischemic cardiomyopathy.
Similar content being viewed by others
References
Chuang ML et al (2000) Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. Int J Card Imaging 16(5):347–357
Klem I et al (2006) Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47(8):1630–1638
Lima JA (2003) Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 42(5):902–904
Amado LC et al (2004) Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 44(12):2383–2389
Kim RJ et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343(20):1445–1453
Kim HW, Farzaneh-Far A, Kim RJ (2009) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55(1):1–16
Kim RJ et al (2008) Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 117(5):629–637
Mahrholdt H et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26(15):1461–1474
McCrohon JA et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108(1):54–59
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018
Casolo G et al (2006) Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. Am Heart J 151(1):101–108
Soriano CJ et al (2005) Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45(5):743–748
Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60(16):1340–1355
Matoh F et al (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 13(5):372–379
Assomull RG et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985
Bogun FM et al (2009) Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 53(13):1138–1145
Duarte S, Bogaert J (2010) The role of cardiac magnetic resonance in hypertrophic cardiomyopathy. Rev Port Cardiol 29(1):79–93
Amano Y, Takayama M, Kumita S (2009) Cardiac magnetic resonance imaging findings are useful for differentiating between hypertrophic obstructive cardiomyopathy and aortic valve stenosis in elderly patients. J Comput Assist Tomogr 33(3):354–358
Rubinshtein R et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3(1):51–58
Ho CY et al (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363(6):552–563
Germans T et al (2010) How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12:13
Choi DS et al (2008) Extent of late gadolinium enhancement in cardiovascular magnetic resonance and its relation with left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Circ J 72(9):1449–1453
Maron MS et al (2008) Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1(3):184–191
Satoh H et al (2009) Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. J Card Fail 15(5):419–427
Kwon DH et al (2008) Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 24(6):617–625
Adabag AS et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51(14):1369–1374
Bruder O et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875–887
Salerno M, Kramer CM (2010) Prognosis in hypertrophic cardiomyopathy with contrast-enhanced cardiac magnetic resonance the future looks bright. J Am Coll Cardiol 56(11):888–889
Di Salvo G et al (2010) Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters. J Am Soc Echocardiogr 23(6):581–590
Leonardi S et al (2009) Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J 30(16):2003–2010
Fluechter S et al (2010) Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 12:30
Pujadas S et al (2010) Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Eur J Radiol 75(2):e88–e91
Abdel-Aty H et al (2008) Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 28(1):242–245
Petersen SE et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115(18):2418–2425
Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343(19):1388–1398
Nelson KH, Li T, Afonso L (2009) Diagnostic approach and role of MRI in the assessment of acute myocarditis. Cardiol Rev 17(1):24–30
Codreanu A et al (2007) Detection of myocarditis by contrast-enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis. J Magn Reson Imaging 25(5):957–964
Roditi GH, Hartnell GG, Cohen MC (2000) MRI changes in myocarditis–evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging. Clin Radiol 55(10):752–758
Zagrosek A et al (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2(2):131–138
Zagrosek A et al (2008) Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis–a CMR study. J Cardiovasc Magn Reson 10:19
Yelgec NS et al (2007) Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Radiol 17(9):2211–2217
Friedrich MG et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53(17):1475–1487
Goitein O et al (2009) Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography. AJR Am J Roentgenol 192(1):254–258
Mahrholdt H et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581–1590
Abdel-Aty H, Simonetti O, Friedrich MG (2007) T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 26(3):452–459
Abdel-Aty H et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45(11):1815–1822
Assomull RG et al (2007) The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 28(10):1242–1249
Thomas B, Ramos R, Tavares NJ (2009) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 6(11): e1; author reply e1–2
Ferrari VA, Scott CH, Basso C (2005) Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Curr Cardiol Rep 7(1):70–75
Corrado D et al (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 30(6):1512–1520
Barahona-Dussault C et al (2010) Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clin Genet 77(1):37–48
Cox MG et al (2009) New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2(5):524–530
Jain R et al (2009) Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation 120(6):477–487
Barrios V, Escobar C, Calderon A (2009) Arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 53(3):295
Wu S et al (2009) Epsilon wave in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Pacing Clin Electrophysiol 32(1):59–63
Marcus FI et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121(13):1533–1541
Jain A et al (2008) Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 10:32
Sen-Chowdhry S et al (2006) Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 48(10):2132–2140
Tandri H et al (2006) Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 48(11):2277–2284
Tandri H et al (2005) Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45(1):98–103
Bomma C et al (2004) Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 15(3):300–306
Roberts WC et al (2010) Some previously neglected examples of arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequency of its various reported manifestations. Am J Cardiol 106(2):268–274
Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112(13):2047–2060
Kwong RY, Falk RH (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111(2):122–124
Vogelsberg H et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51(10):1022–1030
Thomson LEJ (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement. J Am Coll Cardiol 51(10):1031–1032
Bucciarelli-Ducci C et al (2007) Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis. Eur Heart J 28(10):1186
Selvanayagam JB et al (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50(22):2101–2110
Perugini E et al (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92(3):343–349
Maceira AM et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111(2):186–193
Kwong RY, Falk RH (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111(2):122–124
Syed IS et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 3(2):155–164
Maceira AM et al (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54
Ruberg FL et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103(4):544–549
Hiraga H, Yuwai K, Hiroe M (1993) Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare. Japanese Ministry of Health and Welfare, Tokyo, pp 23–24
Smedema JP et al (2005) The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128(3):1629–1637
Hunold P et al (2005) Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 184(5):1420–1426
Tadamura E et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185(1):110–115
Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184(1):249–254
Kiuchi S et al (2007) Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging (formerly Cardiac Imaging) 23(2):237–241
Patel MR et al (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120(20):1969–1977
Finsterer J (2010) Left ventricular non-compaction and its cardiac and neurologic implications. Heart Fail Rev 15(6):589–603
Madan S et al (2010) Left ventricular non-compaction on MRI in a patient with 22q11.2 distal deletion. Am J Med Genet A 152A(5):1295–1299
Luedde M et al (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86(3):452–460
Yousef ZR et al (2009) Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging. BMC Cardiovasc Disord 9:37
Jenni R et al (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86(6):666–671
Varnava AM (2001) Isolated left ventricular non-compaction: a distinct cardiomyopathy? Heart 86(6):599–600
Kohli SK et al (2008) Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 29(1):89–95
Duncan RF, Brown MA, Worthley SG (2008) Increasing identification of isolated left ventricular non-compaction with cardiovascular magnetic resonance: a mini case series highlighting variable clinical presentation. Heart Lung Circ 17(1):9–13
Thuny F et al (2010) Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis 103(3):150–159
Jacquier A et al (2010) Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 31(9):1098–1104
Noetzli LJ et al (2009) Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 114(19):4021–4026
Wood JC et al (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103(5):1934–1936
Westwood M et al (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 18(1):33–39
Kirk P et al (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120(20):1961–1968
Kirk P et al (2010) International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 32(2):315–319
Anderson LJ et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171–2179
Anderson LJ et al (2002) Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 360(9332):516–520
Tanner MA et al (2007) A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115(14):1876–1884
Clarke JT (2007) Narrative review: fabry disease. Ann Intern Med 146(6):425–433
Karamitsos TD et al (2009) The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 54(15):1407–1424
Sachdev B et al (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105(12):1407–1411
Frustaci A et al (2001) Improvement in cardiac function in the cardiac variant of Fabry’s disease with galactose-infusion therapy. N Engl J Med 345(1):25–32
Kanjanauthai S, Ananthasubramaniam K (2007) Integral role of cardiovascular magnetic resonance imaging in the diagnostic workup of suspected takotsubo cardiomyopathy: avoiding misdiagnosis. Cardiol J 14(6):592–594
Wittstein IS et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352(6):539–548
Eitel I et al (2008) Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J 29(21):2651–2659
Abdel-Aty H, Cocker M, Friedrich MG (2009) Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 132(2):291–293
Gerbaud E et al (2008) MRI for the diagnosis of left ventricular apical ballooning syndrome (LVABS). Eur Radiol 18(5):947–954
Singh V et al (2007) Cardiac MRI documented left ventricular thrombus complicating acute takotsubo syndrome: an uncommon dilemma. Int J Cardiovasc Imaging (formerly Cardiac Imaging) 23(5):591–593
Fernandez-Perez GC et al (2010) Takotsubo cardiomyopathy: assessment with cardiac MRI. Am J Roentgenol 195(2):W139–W145
Leurent G et al (2009) Cardiac MRI studies of transient left ventricular apical ballooning syndrome (takotsubo cardiomyopathy): a systematic review. Int J Cardiol 135(2):146–149
Murphy KJ, Brunberg JA (1997) Adult claustrophobia, anxiety and sedation in MRI. Magn Reson Imaging 15(1):51–54
Dantendorfer K et al (1991) Claustrophobia in MRI scanners. Lancet 338(8769):761–762
Phelps LA (1990) MRI and claustrophobia. Am Fam Physician 42(4):930
Gimbel JR (2010) The safety of MRI scanning of pacemakers and ICDs: what are the critical elements of safe scanning? Ask me again at 10, 000. Europace 12(7):915–917
Mollerus M et al (2009) Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 32(6):772–778
Pulver AF et al (2009) Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pacing Clin Electrophysiol 32(4):450–456
Cowper SE (2005) Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 46(4):763–765
Daram SR, Cortese CM, Bastani B (2005) Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46(4):754–759
Perez-Rodriguez J et al (2009) Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment–report of 33 cases. Radiology 250(2):371–377
Runge VM (2009) Gadolinium and nephrogenic systemic fibrosis. AJR Am J Roentgenol 192(4):W195–W196; discussion W197
Perazella MA, Rodby RA (2007) Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease. Am J Med 120(7):561–562
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Mallah, M.H., Shareef, M.N. The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev 16, 369–380 (2011). https://doi.org/10.1007/s10741-010-9221-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-010-9221-3